Clene Inc. (CLNN) came out with a quarterly loss of $0.09 per share in line with the Zacks Consensus Estimate. This compares to loss of$0.15 per share a year ago. These figures are adjusted for non-recurring items. A quarter ago, it was expected that this company would post a loss of $0.07 per share when it actually produced a loss of$0.06, delivering a surprise of 14.29%. Over the last four quarters, the company has surpassed consensus EPS estimates three times. Clene, which belongs to the Zacks Medical ...